These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32700530)

  • 1. Enhancement of a Heroin Vaccine through Hapten Deuteration.
    Belz TF; Bremer PT; Zhou B; Ellis B; Eubanks LM; Janda KD
    J Am Chem Soc; 2020 Aug; 142(31):13294-13298. PubMed ID: 32700530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and immunological effects of heroin vaccines.
    Li F; Cheng K; Antoline JF; Iyer MR; Matyas GR; Torres OB; Jalah R; Beck Z; Alving CR; Parrish DA; Deschamps JR; Jacobson AE; Rice KC
    Org Biomol Chem; 2014 Oct; 12(37):7211-32. PubMed ID: 24995943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfonate-isosteric replacement examined within heroin-hapten vaccine design.
    Belz TF; Bremer PT; Zhou B; Blake S; Ellis B; Eubanks LM; Janda KD
    Bioorg Med Chem Lett; 2020 Sep; 30(17):127388. PubMed ID: 32738981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a deuterated 6-AmHap internal standard for the determination of hapten density in a heroin vaccine drug product.
    Makarova M; Barrientos RC; Torres OB; Matyas GR; Jacobson AE; Sulima A; Rice KC
    J Labelled Comp Radiopharm; 2020 Nov; 63(13):564-571. PubMed ID: 32876947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.
    Jalah R; Torres OB; Mayorov AV; Li F; Antoline JF; Jacobson AE; Rice KC; Deschamps JR; Beck Z; Alving CR; Matyas GR
    Bioconjug Chem; 2015 Jun; 26(6):1041-53. PubMed ID: 25970207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock proteins: A dual carrier-adjuvant for an anti-drug vaccine against heroin.
    Hwang CS; Ellis B; Zhou B; Janda KD
    Bioorg Med Chem; 2019 Jan; 27(1):125-132. PubMed ID: 30497790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and optimization of heroin hapten-BSA conjugates: method development for the synthesis of reproducible hapten-based vaccines.
    Torres OB; Jalah R; Rice KC; Li F; Antoline JF; Iyer MR; Jacobson AE; Boutaghou MN; Alving CR; Matyas GR
    Anal Bioanal Chem; 2014 Sep; 406(24):5927-37. PubMed ID: 25084736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of Abuse.
    Sulima A; Jalah R; Antoline JFG; Torres OB; Imler GH; Deschamps JR; Beck Z; Alving CR; Jacobson AE; Rice KC; Matyas GR
    J Med Chem; 2018 Jan; 61(1):329-343. PubMed ID: 29236495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvements on a chemically contiguous hapten for a vaccine to address fentanyl-contaminated heroin.
    Park H; Lee JC; Eubanks LM; Ellis B; Zhou B; Janda KD
    Bioorg Med Chem; 2021 Jul; 41():116225. PubMed ID: 34034147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs.
    Matyas GR; Mayorov AV; Rice KC; Jacobson AE; Cheng K; Iyer MR; Li F; Beck Z; Janda KD; Alving CR
    Vaccine; 2013 Jun; 31(26):2804-10. PubMed ID: 23624097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple nonradioactive method for the determination of the binding affinities of antibodies induced by hapten bioconjugates for drugs of abuse.
    Torres OB; Antoline JF; Li F; Jalah R; Jacobson AE; Rice KC; Alving CR; Matyas GR
    Anal Bioanal Chem; 2016 Feb; 408(4):1191-204. PubMed ID: 26677020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facial recognition of heroin vaccine opiates: type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphine.
    Matyas GR; Rice KC; Cheng K; Li F; Antoline JF; Iyer MR; Jacobson AE; Mayorov AV; Beck Z; Torres OB; Alving CR
    Vaccine; 2014 Mar; 32(13):1473-9. PubMed ID: 24486371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioids.
    Torres OB; Duval AJ; Sulima A; Antoline JFG; Jacobson AE; Rice KC; Alving CR; Matyas GR
    Anal Bioanal Chem; 2018 Jun; 410(16):3885-3903. PubMed ID: 29675707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A vaccine strategy that induces protective immunity against heroin.
    Stowe GN; Vendruscolo LF; Edwards S; Schlosburg JE; Misra KK; Schulteis G; Mayorov AV; Zakhari JS; Koob GF; Janda KD
    J Med Chem; 2011 Jul; 54(14):5195-204. PubMed ID: 21692508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins.
    Baruffaldi F; Kelcher AH; Laudenbach M; Gradinati V; Limkar A; Roslawski M; Birnbaum A; Lees A; Hassler C; Runyon S; Pravetoni M
    Mol Pharm; 2018 Nov; 15(11):4947-4962. PubMed ID: 30240216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the effects of a hydrolytically stable hapten and a Th1 adjuvant on heroin vaccine performance.
    Bremer PT; Janda KD
    J Med Chem; 2012 Dec; 55(23):10776-80. PubMed ID: 23134263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating hapten clustering as a strategy to enhance vaccines against drugs of abuse.
    Collins KC; Janda KD
    Bioconjug Chem; 2014 Mar; 25(3):593-600. PubMed ID: 24521489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the effects of hapten stability on cocaine vaccine immunogenicity.
    Cai X; Whitfield T; Moreno AY; Grant Y; Hixon MS; Koob GF; Janda KD
    Mol Pharm; 2013 Nov; 10(11):4176-84. PubMed ID: 23927436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hapten-specific naïve B cells are biomarkers of vaccine efficacy against drugs of abuse.
    Taylor JJ; Laudenbach M; Tucker AM; Jenkins MK; Pravetoni M
    J Immunol Methods; 2014 Mar; 405():74-86. PubMed ID: 24462800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequence of Hapten Stereochemistry: An Efficacious Methamphetamine Vaccine.
    Olson ME; Sugane T; Zhou B; Janda KD
    J Am Chem Soc; 2019 Sep; 141(36):14089-14092. PubMed ID: 31479256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.